_version_ 1783689080518737920
author Lobello, Cosimo
Tichy, Boris
Bystry, Vojtech
Radova, Lenka
Filip, Daniel
Mraz, Marek
Montes-Mojarro, Ivonne-Aidee
Prokoph, Nina
Larose, Hugo
Liang, Huan-Chang
Sharma, Geeta G.
Mologni, Luca
Belada, David
Kamaradova, Katerina
Fend, Falko
Gambacorti-Passerini, Carlo
Merkel, Olaf
Turner, Suzanne D.
Janikova, Andrea
Pospisilova, Sarka
author_facet Lobello, Cosimo
Tichy, Boris
Bystry, Vojtech
Radova, Lenka
Filip, Daniel
Mraz, Marek
Montes-Mojarro, Ivonne-Aidee
Prokoph, Nina
Larose, Hugo
Liang, Huan-Chang
Sharma, Geeta G.
Mologni, Luca
Belada, David
Kamaradova, Katerina
Fend, Falko
Gambacorti-Passerini, Carlo
Merkel, Olaf
Turner, Suzanne D.
Janikova, Andrea
Pospisilova, Sarka
author_sort Lobello, Cosimo
collection PubMed
description
format Online
Article
Text
id pubmed-8102183
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81021832021-05-24 STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma Lobello, Cosimo Tichy, Boris Bystry, Vojtech Radova, Lenka Filip, Daniel Mraz, Marek Montes-Mojarro, Ivonne-Aidee Prokoph, Nina Larose, Hugo Liang, Huan-Chang Sharma, Geeta G. Mologni, Luca Belada, David Kamaradova, Katerina Fend, Falko Gambacorti-Passerini, Carlo Merkel, Olaf Turner, Suzanne D. Janikova, Andrea Pospisilova, Sarka Leukemia Letter Nature Publishing Group UK 2020-11-27 2021 /pmc/articles/PMC8102183/ /pubmed/33247178 http://dx.doi.org/10.1038/s41375-020-01093-1 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Lobello, Cosimo
Tichy, Boris
Bystry, Vojtech
Radova, Lenka
Filip, Daniel
Mraz, Marek
Montes-Mojarro, Ivonne-Aidee
Prokoph, Nina
Larose, Hugo
Liang, Huan-Chang
Sharma, Geeta G.
Mologni, Luca
Belada, David
Kamaradova, Katerina
Fend, Falko
Gambacorti-Passerini, Carlo
Merkel, Olaf
Turner, Suzanne D.
Janikova, Andrea
Pospisilova, Sarka
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
title STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
title_full STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
title_fullStr STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
title_full_unstemmed STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
title_short STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
title_sort stat3 and tp53 mutations associate with poor prognosis in anaplastic large cell lymphoma
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102183/
https://www.ncbi.nlm.nih.gov/pubmed/33247178
http://dx.doi.org/10.1038/s41375-020-01093-1
work_keys_str_mv AT lobellocosimo stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT tichyboris stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT bystryvojtech stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT radovalenka stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT filipdaniel stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT mrazmarek stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT montesmojarroivonneaidee stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT prokophnina stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT larosehugo stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT lianghuanchang stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT sharmageetag stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT mologniluca stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT beladadavid stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT kamaradovakaterina stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT fendfalko stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT gambacortipasserinicarlo stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT merkelolaf stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT turnersuzanned stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT janikovaandrea stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma
AT pospisilovasarka stat3andtp53mutationsassociatewithpoorprognosisinanaplasticlargecelllymphoma